|
[1]
|
Murray, C.J.L. and Lopez, A.D. (2013) Measuring the Global Burden of Disease. The New England Journal of Medicine, 369, 448-457. [Google Scholar] [CrossRef]
|
|
[2]
|
Simon, I.H., Amanuel, A.A., Kalkidan, H.A., et al. (2017) Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet, 390, 1260-1344. [Google Scholar] [CrossRef]
|
|
[3]
|
Hansson, G.K. and Hermansson, A. (2011) The Immune System in Atherosclerosis. Nature Immunology, 12, 204-212. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Libby, P., Lichtman, A.H. and Hansson, G.K. (2013) Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans. Immunity, 38, 1092-1104. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Duewell, P., Kono, H., Rayner, K.J., et al. (2010) NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals. Nature, 464, 1357-1361. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Baldrighi, M., Mallat, Z. and Li, X. (2017) NLRP3 Inflammasome Pathways in Atherosclerosis. Atherosclerosis, 267, 127-138. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Xiao, H., Lu, M., Lin, T.Y., et al. (2013) Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility. Circulation, 128, 632-642. [Google Scholar] [CrossRef]
|
|
[8]
|
Alena, G., Florian, H. and Eicke, L. (2018) NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circulation Research, 122, 1722-1740. [Google Scholar] [CrossRef]
|
|
[9]
|
Zheng, F., Xing, S.S., Gong, Z.S., Xing, Q.C. (2013) NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis. Heart Lung & Circulation, 22, 746-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Varghese, G.P., Folkersen, L., Strawbridge, R.J., et al. (2016) NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis. Journal of the American Heart Association, 5, e003031. [Google Scholar] [CrossRef]
|
|
[11]
|
Virgilio, F.D., Ben, D.D., Sarti, A.C., et al. (2017) The P2X7 Receptor in Infection and Inflammation. Immunity, 47, 15-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Peng, K., Liu, L., Wei, D., et al. (2015) P2X7R Is Involved in the Progression of Atherosclerosis by Promoting NLRP3 Inflammasome Activation. International Journal of Molecular Medicine, 35, 1179-1188. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Faraoni, I., Antonetti, F.R., Cardone, J. and Bonmassar, E. (2009) miR-155 Gene: A Typical Multifunctional microRNA. Biochimica et Biophysica Acta, 1792, 497-505. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Yin, R.H., Zhu, X.Y., Wang, J., Yang, S.N., Ma, A.J., Xiao, Q., Song, J.Y. and Pan, X.D. (2019) MicroRNA-155 Promotes the Ox-LDL-Induced Activation of NLRP3 Inflammasomes via the ERK1/2 Pathway in THP-1 Macrophages and Aggravates Atherosclerosis in ApoE-/- Mice. Annals of Palliative Medicine, 8, 676-689. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Artlett, C.M., Sassi-Gaha, S., Hope, J.L., Feghali-Bostwick, C.A. and Katsikis, P.D. (2017) Mir-155 Is Overexpressed in Systemic Sclerosis Fibroblasts and Is Required for NLRP3 Inflammasome-Mediated Collagen Synthesis during Fibrosis. Annals of Palliative Medicine, 19, Article No. 144. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Luo, Q., Zeng, J.X., Li, W., Lin, L., Zhou, X., Tian, X., Liu, W.Y., Zhang, L.D. and Zhang, X.B. (2018) Silencing of miR-155 Suppresses Inflammatory Responses in Psoriasis through Inflammasome NLRP3 Regulation. International Journal of Molecular Medicine, 42, 1086-1095. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Chen, S., Smith, B. A. H., Iype, J., et al. (2015) MicroRNA-155-Deficient Dendritic Cells Cause Less Severe GVHD through Reduced Migration and Defective Inflammasome Activation. Blood, 126, 103-112. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Piscopiello, M., Sessa, M., Anzalone, N., et al. (2013) P2X7 Receptor Is Expressed in Human Vessels and Might Play a Role in Atherosclerosis. International Journal of Cardiology, 168, 2863-2866. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Lin, L., Huang, S.J., Zhu, Z.Y., Han, J.B., Wang, Z.X., Huang, W.J. and Huang, Z.Q. (2018) P2X7 Receptor Regulates EMMPRIN and MMP-9 Expression through AMPK/MAPK Signaling in PMA-Induced Macrophages. Molecular Medicine Reports, 18, 3027-3033. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Garcia-Martinez, I., Shaker, M.E. and Mehal, W.Z. (2015) Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases. Antioxidants & Redox Signaling, 23, 1305-1315. [Google Scholar] [CrossRef] [PubMed]
|